Treatment with tralokinumab improves health-related quality of life in adult patients with moderate to severe atopic dermatitis: results from a Phase 2b, randomised, double-blind, placebo-controlled study. J of Skin. 2018;2:S64. doi:10.25251/skin.2.supp.64